| pubmed-article:7692660 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7692660 | lifeskim:mentions | umls-concept:C0019004 | lld:lifeskim |
| pubmed-article:7692660 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
| pubmed-article:7692660 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:7692660 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7692660 | pubmed:dateCreated | 1993-11-19 | lld:pubmed |
| pubmed-article:7692660 | pubmed:abstractText | We undertook a prospective study to evaluate the effects of hemodialysis on serum prostate-specific antigen (PSA) in 26 male patients with end-stage renal disease as a clinical model for assessing the role of the kidney in PSA clearance. Patients ranging in age from fifty-one to eighty-three years (mean 64.8 years) underwent phlebotomy immediately before and after outpatient hemodialysis on a Monday/Wednesday/Friday or Tuesday/Thursday/Saturday schedule, with serum PSA values determined by the Abbott IMX Microparticle Enzyme Immunoassay. The mean +/- standard deviation for all post-dialysis PSA levels, 2.43 +/- 3.74, was significantly greater than that for pre-dialysis levels, 2.11 +/- 3.19 (p = 0.04). However, no statistically significant differences were found on comparing the combined pre- and post-dialysis PSA values over the course of the study (p = 0.2733) or when sequential pre-dialysis (p = 0.28) and post-dialysis (p = 0.92) levels were analyzed separately. We conclude that PSA is not eliminated by hemodialysis, and our results infer that it is not cleared by renal mechanisms. | lld:pubmed |
| pubmed-article:7692660 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7692660 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7692660 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7692660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7692660 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7692660 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7692660 | pubmed:issn | 0090-4295 | lld:pubmed |
| pubmed-article:7692660 | pubmed:author | pubmed-author:PittawayD EDE | lld:pubmed |
| pubmed-article:7692660 | pubmed:author | pubmed-author:RussellG BGB | lld:pubmed |
| pubmed-article:7692660 | pubmed:author | pubmed-author:FreedmanB IBI | lld:pubmed |
| pubmed-article:7692660 | pubmed:author | pubmed-author:BurkartJ MJM | lld:pubmed |
| pubmed-article:7692660 | pubmed:author | pubmed-author:AssimosD GDG | lld:pubmed |
| pubmed-article:7692660 | pubmed:author | pubmed-author:MonathJ RJR | lld:pubmed |
| pubmed-article:7692660 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7692660 | pubmed:volume | 42 | lld:pubmed |
| pubmed-article:7692660 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7692660 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7692660 | pubmed:pagination | 398-400 | lld:pubmed |
| pubmed-article:7692660 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7692660 | pubmed:meshHeading | pubmed-meshheading:7692660-... | lld:pubmed |
| pubmed-article:7692660 | pubmed:meshHeading | pubmed-meshheading:7692660-... | lld:pubmed |
| pubmed-article:7692660 | pubmed:meshHeading | pubmed-meshheading:7692660-... | lld:pubmed |
| pubmed-article:7692660 | pubmed:meshHeading | pubmed-meshheading:7692660-... | lld:pubmed |
| pubmed-article:7692660 | pubmed:meshHeading | pubmed-meshheading:7692660-... | lld:pubmed |
| pubmed-article:7692660 | pubmed:meshHeading | pubmed-meshheading:7692660-... | lld:pubmed |
| pubmed-article:7692660 | pubmed:meshHeading | pubmed-meshheading:7692660-... | lld:pubmed |
| pubmed-article:7692660 | pubmed:meshHeading | pubmed-meshheading:7692660-... | lld:pubmed |
| pubmed-article:7692660 | pubmed:meshHeading | pubmed-meshheading:7692660-... | lld:pubmed |
| pubmed-article:7692660 | pubmed:meshHeading | pubmed-meshheading:7692660-... | lld:pubmed |
| pubmed-article:7692660 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:7692660 | pubmed:articleTitle | Effects of hemodialysis on prostate-specific antigen. | lld:pubmed |
| pubmed-article:7692660 | pubmed:affiliation | Department of Urology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina. | lld:pubmed |
| pubmed-article:7692660 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7692660 | pubmed:publicationType | Comparative Study | lld:pubmed |
